These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5759964)

  • 41. Evaluation of B.663 in human leprosy.
    Atkinson AJ; Sheagren JN; Rubio JB; Knight V
    Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
    [No Abstract]   [Full Text] [Related]  

  • 42. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 43. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
    Sakurai I; Skinsnes OK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
    Rostant MM
    Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine.
    Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH
    Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084
    [No Abstract]   [Full Text] [Related]  

  • 46. A study of skin pigmentation by clofazimine.
    Levy L; Randall HP
    Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
    [No Abstract]   [Full Text] [Related]  

  • 47. B 663 (Lampren) in mycobacterial infections.
    Pettit JH
    Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
    [No Abstract]   [Full Text] [Related]  

  • 48. [Action of 2 new products, thalidomide and B. 663 on reactive forms of Hansen's disease].
    Languillon J
    Med Trop (Mars); 1969; 29(4):497-503. PubMed ID: 5403099
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies of experimental chemotherapy of leprosy.
    Banerjee DK
    Lepr India; 1976 Oct; 48(4 Suppl):686-9. PubMed ID: 800233
    [No Abstract]   [Full Text] [Related]  

  • 50. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082
    [No Abstract]   [Full Text] [Related]  

  • 51. Phagocytosis-promoting effect of clofazimine (B 663) in patients with subnormal granulocyte function.
    Brandt L
    Scand J Haematol; 1971; 8(5):400-4. PubMed ID: 5289696
    [No Abstract]   [Full Text] [Related]  

  • 52. Clofazimine (Lamprene) in leprosy.
    Drug Ther Bull; 1970 Jan; 8(2):7-8. PubMed ID: 4903794
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of leprosy using sulfamethoxypyrimidine].
    Mattos O; Rabelo Neto AV
    Rev Bras Med; 1970 Jun; 27(6):328-30. PubMed ID: 5488613
    [No Abstract]   [Full Text] [Related]  

  • 54. Antimalarial effect of B.663 in mice infected with Plasmodium berghei.
    Sheagren JN
    J Parasitol; 1968 Dec; 54(6):1250-1. PubMed ID: 5757702
    [No Abstract]   [Full Text] [Related]  

  • 55. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
    [No Abstract]   [Full Text] [Related]  

  • 56. G 30 320 or B 663--lampren (Geigy).
    Waters MF
    Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382
    [No Abstract]   [Full Text] [Related]  

  • 57. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New methods of experimental chemotherapy in leprosy].
    Wagner WH
    Hautarzt; 1969 Sep; 20(9):385-9. PubMed ID: 4191849
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical evaluation of Lamprene (Geigy). A preliminary report.
    Karuru ER
    Lepr Rev; 1970 Apr; 41(2):83-8. PubMed ID: 5453083
    [No Abstract]   [Full Text] [Related]  

  • 60. Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Marques RM
    Int J Lepr Other Mycobact Dis; 1970; 38(3):250-63. PubMed ID: 4993550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.